Controversies in Breast Cancer Screening Strategies.

Published

Conference Paper

A panel discussion on controversies in breast cancer screening held recently at the NCCN 21st Annual Conference included only a few controversies. Representatives of the U.S. Preventive Services Task Force, American Cancer Society, and NCCN disagreed primarily on 2 main areas: when to start screening (ages 40, 45, or 50 years) and frequency of screening (annual vs biennial). Panelists from these organizations presented the rationales for their respective recommendations.

Full Text

Duke Authors

Cited Authors

  • Bevers, T; Bibbins-Domingo, K; Oeffinger, KC; Smith, ML

Published Date

  • May 2016

Published In

Volume / Issue

  • 14 / 5 Suppl

Start / End Page

  • 651 - 653

PubMed ID

  • 27226505

Pubmed Central ID

  • 27226505

Electronic International Standard Serial Number (EISSN)

  • 1540-1413

Conference Location

  • United States